Deoxyribonucleotide Formation (Ribonucleotide Reductase pathway and thymidylate synthesis)
- Compartment
- Cytosol
- Main tissue
- Proliferating cells
- Rate-limiting
- Ribonucleotide reductase (RNR, class Ia)
- Steps
- 12
Reaction steps
In source order, 12 total
-
1
Nucleoside diphosphates → deoxyribonucleoside diphosphates
› Notes
Class Ia RNR catalyzes ADP, GDP, CDP, or UDP + reducing equivalents → dADP, dGDP, dCDP, or dUDP + oxidized electron-transfer proteins. The human enzyme is an alpha2beta2 complex: the RRM2/RRM2B small subunit uses a diiron center to generate a stable tyrosyl radical, and the RRM1 large subunit contains catalytic cysteines that reduce the 2′-hydroxyl group. Reducing equivalents are transferred from NADPH through thioredoxin reductase and reduced thioredoxin (or through NADPH, glutathione reductase, glutathione, and glutaredoxin); the chemical reduction of each NDP requires one NADPH-derived pair of electrons. This is the rate-limiting and committed step for de novo deoxyribonucleotide production.
-
2
Oxidized thioredoxin → reduced thioredoxin
› Notes
Thioredoxin reductase catalyzes oxidized thioredoxin + NADPH + H+ → reduced thioredoxin + NADP+. This FAD- and selenocysteine-containing flavoprotein restores the RNR electron donor after each catalytic cycle. The glutaredoxin alternative is sustained by glutathione reductase, which uses NADPH to regenerate reduced glutathione.
-
3
dADP, dGDP, dCDP, or dUDP → corresponding dNTP
› Notes
NDPK catalyzes dNDP + ATP (or another NTP) ⇌ dNTP + ADP. This near-equilibrium phosphotransfer uses a phosphohistidine intermediate and supplies dATP, dGTP, dCTP, and dUTP from the RNR products.
-
4
dUDP → dUTP → dUMP
↪ dUTP → dUMP
Nucleoside diphosphate kinase (NDPK) + dUTPase 2.7.4.6 / 3.6.1.23 ST-0255 Irreversible/directional H2O PPi› Notes
NDPK phosphorylates dUDP to dUTP, and dUTPase hydrolyzes dUTP + H2O → dUMP + PPi. dUTPase is functionally crucial: it creates dUMP while minimizing dUTP incorporation into DNA, which would otherwise initiate repeated uracil-excision repair.
-
5
dCMP → dUMP
› Notes
dCMP deaminase catalyzes dCMP + H2O → dUMP + NH3. The enzyme provides a second dUMP source and uses allosteric control to coordinate dCTP and dTTP pools; dCTP generally activates and dTTP inhibits the enzyme.
-
6
dUMP → dTMP
› Notes
Thymidylate synthase (TYMS) catalyzes dUMP + 5,10-methylene-THF → dTMP + DHF. An active-site cysteine forms a covalent intermediate with dUMP, and 5,10-methylene-THF provides the methylene group and the reducing hydride equivalent; this is the committed, effectively irreversible step of de novo dTMP synthesis.
-
7
DHF → THF
› Notes
DHFR catalyzes DHF + NADPH + H+ → THF + NADP+. This reaction regenerates reduced folate after every thymidylate synthase turnover and is essential to maintain dTMP synthesis.
-
8
THF → 5,10-methylene-THF
Serine hydroxymethyltransferase (SHMT1/SHMT2) 2.1.2.1 ST-0259 Irreversible/directional PLP (B6) THF (folate)› Notes
Serine hydroxymethyltransferase (SHMT) catalyzes serine + THF ⇌ glycine + 5,10-methylene-THF, requiring pyridoxal phosphate. The folate-bound one-carbon unit can also be supplied through the cytosolic mitochondrial one-carbon network; adequate folate metabolism is required to sustain this step.
-
9
dTMP → dTDP
› Notes
Thymidylate kinase catalyzes dTMP + ATP → dTDP + ADP. This kinase is specific for thymidylate and is required before dTTP can be generated.
-
10
dTDP → dTTP
› Notes
NDPK catalyzes dTDP + ATP (or another NTP) ⇌ dTTP + ADP. dTTP then participates in DNA polymerization and also serves as an allosteric specificity effector for RNR and an inhibitor of dCMP deaminase.
-
11
Ribonucleoside triphosphates → dNDP precursor pool
Nucleoside diphosphate kinases/phosphatases (NTP<->NDP pool) 2.7.4.6 ST-0262 Irreversible/directional› Notes
Nucleoside diphosphate phosphatases/kinases maintain interconversion between NTP and NDP pools so that ADP, GDP, CDP, and UDP are available to RNR. RNR acts on diphosphates, not directly on NTPs, a feature central to its allosteric substrate-specificity system.
-
12
Deoxycytidine or thymidine → dCMP or dTMP (salvage support)
› Notes
Cytosolic deoxycytidine kinase phosphorylates deoxycytidine + ATP → dCMP + ADP, while cytosolic thymidine kinase 1 phosphorylates thymidine + ATP → dTMP + ADP in S phase; mitochondrial thymidine kinase 2 supports mitochondrial dTTP supply in nondividing cells. These are salvage reactions, not de novo formation, but they can bypass part of the RNR/thymidylate pathway and materially affect dNTP homeostasis.
Showing all 12 steps.
Regulation
What speeds each enzyme up and what slows it down
Ribonucleotide reductase (RNR)
ATP at the activity site; substrate specificity is directed by ATP/dATP, dTTP, and dGTP at the specificity site
dATP at the activity site (global feedback inhibition); hydroxyurea quenches the radical; iron limitation impairs radical-center assembly
Transcription and activity rise in late G1/S through E2F and proliferative growth-factor signaling; p53-induced RRM2B supports DNA repair under stress.
dCMP deaminase
dCTP (allosteric activation)
dTTP (allosteric inhibition)
Cell-cycle-linked expression; no major direct endocrine allostery.
Thymidylate synthase
dUMP and 5,10-methylene-THF availability
5-fluoro-dUMP (stable covalent ternary complex with 5,10-methylene-THF); product/pool feedback by dTMP/dTTP
S-phase/E2F-associated induction in proliferating cells rather than a direct hormonal switch.
Dihydrofolate reductase
DHF and NADPH availability
Methotrexate, trimethoprim (much greater selectivity for microbial DHFR), pemetrexed
Proliferation-associated transcriptional induction; no canonical acute hormonal allosteric regulator.
Overview
Deoxyribonucleotide formation converts ribonucleotide pools into the balanced deoxyribonucleoside triphosphate (dNTP) pools required for faithful DNA replication and repair. Ribonucleotide reductase (RNR) reduces ribonucleoside diphosphates, whereas thymidylate synthase uniquely creates the methylated pyrimidine nucleotide dTMP from dUMP. Tight allosteric and cell-cycle regulation is essential because either shortage or imbalance of dNTPs increases replication stress, mutagenesis, and genome instability.
Cellular location
RNR large and small subunits are predominantly cytosolic but are regulated by cell cycle and can redistribute to support nuclear DNA synthesis; dNTPs are transported or locally generated for nuclear and mitochondrial DNA replication. Thymidylate synthase, DHFR, and folate enzymes are cytosolic and can form a replication-associated nuclear complex during S phase. Mitochondria maintain distinct dNTP homeostasis using mitochondrial dGK, thymidine kinase 2, and dedicated transport/metabolic systems, especially in nondividing cells.
Net energetics
RNR reduction of one NDP to one dNDP consumes one NADPH-derived reducing equivalent through thioredoxin or glutaredoxin systems; RNR itself does not hydrolyze ATP in the reduction reaction. Phosphorylation of dNDP to dNTP costs one NTP → NDP equivalent. For each dTMP formed from dUMP, thymidylate synthase consumes one 5,10-methylene-THF molecule and produces DHF; DHFR consumes one NADPH to regenerate THF, while SHMT supplies the methylene group from serine. Conversion of dTMP to dTTP requires two ATP-equivalent phosphorylations (dTMP kinase and NDPK); the cost of forming dUMP additionally depends on whether it arises from dUDP/dUTP or dCMP deamination.
Clinical significance
Balanced dNTP pools are indispensable for DNA replication, base-excision repair, and mitochondrial genome maintenance; excessive dATP, for example, can inhibit RNR and disrupt overall pool balance. Hydroxyurea inhibits RNR by quenching its tyrosyl radical and is used in myeloproliferative disorders and to induce fetal hemoglobin in sickle cell disease. 5-fluorouracil inhibits thymidylate synthase after conversion to 5-fluoro-dUMP, whereas methotrexate inhibits DHFR and causes functional depletion of reduced folates; leucovorin can enhance 5-fluorouracil-mediated thymidylate synthase inhibition or rescue selected antifolate effects. Folate deficiency produces impaired dTMP synthesis, uracil misincorporation, megaloblastic anemia, and chromosomal instability. Energy metabolism and cellular respiration integrate the oxidative pathways that convert carbon fuels into ATP, culminating in the citric acid cycle, electron transport chain, and oxidative phosphorylation. These pathways represent the convergence point for carbohydrate, lipid, and amino acid catabolism and are the primary determinant of cellular ATP yield under aerobic and anaerobic conditions. Mitochondrial dysfunction in this category underlies a wide range of metabolic and neurodegenerative disease.
Recent literature
Live Europe PMC search
Europe PMC · from cache · sorted by publication date
-
1
Understanding cataract development in axial myopia: The contribution of oxidative stress and related pathways.
Świerczyńska M, Tronina A, Smędowski A. · 2025-01-10
cited 9× open access unreviewed -
2
HnRNP Pathologies in Frontotemporal Lobar Degeneration.
Jiang X, Gatt A, Lashley T. · 2023-06-15
cited 9× open access unreviewed -
3
Mitochondria and Iron: current questions.
Paul BT, Manz DH, Torti FM, Torti SV. · 2016-12-12
cited 354× unreviewed -
4
RRM1 *151A>T, RRM1 -756T>C, and RRM1 -585T>Gis associated with increased susceptibility of lung cancer in Chinese patients.
Xu XL, Zheng J, Mao WM, Ling ZQ. · 2016-06-23
cited 8× open access unreviewed -
5
The case for an early biological origin of DNA.
Poole AM, Horinouchi N, Catchpole RJ, Si D, Hibi M, Tanaka K, Ogawa J. · 2014-11-26
cited 18× open access unreviewed -
6
A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer.
El-Khoueiry AB, Ramanathan RK, Yang DY, Zhang W, Shibata S, Wright JJ, Gandara D, Lenz HJ. · 2011-03-22
cited 37× unreviewed -
7
Proteomic analysis of endothelial cold-adaptation.
Zieger MA, Gupta MP, Wang M. · 2011-12-22
cited 14× open access unreviewed -
8
RRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy.
Dong S, Guo AL, Chen ZH, Wang Z, Zhang XC, Huang Y, Xie Z, Yan HH, Cheng H, Wu YL. · 2010-03-13
cited 29× open access unreviewed -
9
Neuroprotective activity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (PAN-811), a cancer therapeutic agent.
Jiang ZG, Lebowitz MS, Ghanbari HA. · 2006-01-01
cited 18× unreviewed -
10
Glutathione synthesis is essential for mouse development but not for cell growth in culture.
Shi ZZ, Osei-Frimpong J, Kala G, Kala SV, Barrios RJ, Habib GM, Lukin DJ, Danney CM, Matzuk MM, Lieberman MW. · 2000-05-01
cited 231× unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.